Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com 0 Related Posts Skyharbour Resources June 14, 2025 Juggernaut Exploration June 14, 2025 Grande Portage Closes Non-Brokered Private Placement Pursuant to the Listed Issuer Financing Exemption June 14, 2025
Grande Portage Closes Non-Brokered Private Placement Pursuant to the Listed Issuer Financing Exemption June 14, 2025